Results 261 to 270 of about 113,809 (305)
Some of the next articles are maybe not open access.
Annals of Internal Medicine, 1978
Excerpt To the editor: To prove that tamoxifen causes hypercalcemia in advanced breast cancer, as has been suggested by Veldhuis (1) and others (2-4), would require that three criteria be met.
K I, Pritchard +5 more
+7 more sources
Excerpt To the editor: To prove that tamoxifen causes hypercalcemia in advanced breast cancer, as has been suggested by Veldhuis (1) and others (2-4), would require that three criteria be met.
K I, Pritchard +5 more
+7 more sources
Survey of Ophthalmology, 2023
Tamoxifen (TAM) is a selective estrogen receptor modulator that is used in the treatment of breast cancer. As there are estrogen receptors in the retina, retinal pigment epithelium, and choroid, these tissues may also be affected by TAM. We describe the reported effects of TAM on the retina and choroid.
Fatemeh Bazvand +6 more
openaire +2 more sources
Tamoxifen (TAM) is a selective estrogen receptor modulator that is used in the treatment of breast cancer. As there are estrogen receptors in the retina, retinal pigment epithelium, and choroid, these tissues may also be affected by TAM. We describe the reported effects of TAM on the retina and choroid.
Fatemeh Bazvand +6 more
openaire +2 more sources
Archives of Andrology, 1985
Thirty normogonadotropic oligospermic males were administered Tamoxifen (20 mg/day) for 4 months. A complete evaluation of seminal parameters before and after treatment was performed. An increase of both mean sperm concentration and total sperm count was noted after treatment with Tamoxifen (p less than 0.05), whereas no variation was observed for ...
I, Noci +4 more
openaire +2 more sources
Thirty normogonadotropic oligospermic males were administered Tamoxifen (20 mg/day) for 4 months. A complete evaluation of seminal parameters before and after treatment was performed. An increase of both mean sperm concentration and total sperm count was noted after treatment with Tamoxifen (p less than 0.05), whereas no variation was observed for ...
I, Noci +4 more
openaire +2 more sources
1998
Tamoxifen, a nonsteroidal antiestrogen, was first approved by the Food and Drug Administration in 1978 for the treatment of patients with breast cancer. Large clinical trials involving over 75,000 patients have demonstrated an improved recurrence-free and overall survival benefit in both premenopausal and postmenopausal women.
openaire +2 more sources
Tamoxifen, a nonsteroidal antiestrogen, was first approved by the Food and Drug Administration in 1978 for the treatment of patients with breast cancer. Large clinical trials involving over 75,000 patients have demonstrated an improved recurrence-free and overall survival benefit in both premenopausal and postmenopausal women.
openaire +2 more sources
Science Signaling, 2017
Antiestrogen drugs may treat some estrogen receptor–negative tumors by limiting the proliferation and activity of suppressive immune cells.
openaire +2 more sources
Antiestrogen drugs may treat some estrogen receptor–negative tumors by limiting the proliferation and activity of suppressive immune cells.
openaire +2 more sources